| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;70:1168-1171
© 2000 The Society of Thoracic Surgeons
a Divisions of Hematology, University of Arkansas of Medical Sciences, Little Rock, Arkansas, USA
b Oncology and Thoracic Surgery, University of arkansas for Medical Sciences, Little Rock, Arkansas, USA
c Department of Pathology, University of Arkansas for Medical Sciences, Central Arkansas Veterans Health Care System, Little Rock, Arkansas, USA
d Division of Thoracic Surgery, Central Arkansas Veterans Health Care System, Little Rock, Arkansas, USA
Address reprint requests to Dr Jazieh, Division of Hematology and Oncology, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 508, Little Rock, AR 72205
e-mail: jaziehabdulr{at}exchange.uams.edu
Background. About one-third to one-half of patients with early stages of non-small cell lung cancer (NSCLC) succumb to their disease. In this study, we attempted to identify prognostic factors that predict outcome in patients with stages I and II NSCLC.
Methods. A retrospective evaluation of 454 patients with surgically resected stages I and II NSCLC was performed to determine the impact of various clinical, laboratory, and pathological factors on patient outcome such as overall survival (OS) and event-free survival (EFS).
Results. Patients older than 65 years had shorter EFS and OS than younger patients (p = 0.002). Patients with preoperative hemoglobin less than or equal to 10 g% had shorter EFS and OS compared to patients with a hemoglobin greater than 10 g% (p = 0.001). Expectedly, OS and EFS were shorter in patients with stage II as compared to stage I patients (p < 0.001). In a multivariate analysis, age, hemoglobin level, and stage remain significant predictors for EFS and OS.
Conclusions. Older age, anemia, and higher stage are important prognostic factors in patients with surgically resected stage I and II NSCLC.
This article has been cited by other articles:
|
|
 |
|
  K. M. Akgun, K. Crothers, and M. Pisani Epidemiology and Management of Common Pulmonary Diseases in Older Persons J Gerontol A Biol Sci Med Sci, March 1, 2012; 67A(3): 276 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Cosio and A. Agusti Comorbidity: a distinctive feature of elderly respiratory patients Respiratory Diseases in the Elderly, June 10, 2010; 205 - 216. [Abstract] [Fulltext] [PDF]
|
|
|
|
 |
|
 E. Marret, F. Miled, B. Bazelly, S. El Metaoua, J. de Montblanc, C. Quesnel, J.-P. Fulgencio, and F. Bonnet Risk and protective factors for major complications after pneumonectomy for lung cancer Interact CardioVasc Thorac Surg, June 1, 2010; 10(6): 936 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-K. Hsu, H.-C. Huang, C.-C. Hsieh, H.-S. Hsu, Y.-C. Wu, M.-H. Huang, and W.-H. Hsu Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., December 1, 2007; 84(6): 1825 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Sun, M.-C. Aubry, C. Deschamps, R. S. Marks, S. H. Okuno, B. A. Williams, H. Sugimura, V. S. Pankratz, and P. Yang Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: An analysis of 5018 hospital- and 712 population-based cases J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1014 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T C Mineo, V Ambrogi, A Baldi, C Rabitti, P Bollero, B Vincenzi, and G Tonini Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer J. Clin. Pathol., June 1, 2004; 57(6): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Booton, M Jones, and N Thatcher Lung cancer * 7: Management of lung cancer in elderly patients Thorax, August 1, 2003; 58(8): 711 - 720. [Full Text] [PDF]
|
|
|
|
|
|
Y. Refaely, S. Sadetzki, A. Chetrit, D. A. Simansky, M. Paley, B. Modan, and A. Yellin The sequence of vessel interruption during lobectomy for non-small cell lung cancer: Is it indeed important? J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1313 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Myrdal, M. Lambe, G. Gustafsson, K. Nilsson, and E. Stahle Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics Ann. Thorac. Surg., February 1, 2003; 75(2): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-R. Jazieh and J. A. Howington Reply Ann. Thorac. Surg., June 1, 2002; 73(6): 2035 - 2035. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Jazieh, M. J. Kyasa, G. Sethuraman, and J. Howington Disparities in surgical resection of early-stage non-small cell lung cancer J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1173 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Watine and P. Berteau Blood hemoglobin as an independent prognostic factor in surgically resected stages I and II non-small cell lung cancer patients Ann. Thorac. Surg., June 1, 2002; 73(6): 2034 - 2035. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
